A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus

NCT07073170 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: LY3549492
DRUG: Placebo

Sponsor

Eli Lilly and Company